ESC Premium Access

From identification of high CV risk patients to treatment with PCSK9i: learnings from ODYSSEY OUTCOMES.

Congress Presentation

About the speaker

Professor Andreas Michael Zeiher

Institute of Cardiovascular Regeneration, Frankfurt (Germany)
11 presentations
0 follower

2 more presentations in this session

A deeper dive into key ODYSSEY OUTCOMES results and their impact on patient management.

Speaker: Professor G. Schwartz (Aurora, US)

Thumbnail

Interaction with the audience

Speaker: Professor A. Zeiher (Frankfurt, DE)

Thumbnail

Access the full session

From ODYSSEY OUTCOMES results to clinical practice - Identifying patients who may benefit most from PCSK9 inhibition

Speakers: Professor A. Zeiher, Professor G. Schwartz, Professor A. Zeiher
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb